PT Kalbe Farma, Southeast Asia’s biggest publicly traded pharmaceutical company, may acquire a drug developer and health food brands overseas to expand as competition intensifies at home and growth slows.
PT Kalbe Farma, Southeast Asia’s biggest publicly traded pharmaceutical company, may acquire a drug developer and health food brands overseas to expand as competition intensifies at home and growth slows.
